|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Welch Allyn Restructuring European Operations
12/11/2012 8:53:00 AM
Medical device maker Welch Allyn Monday announced plans to create a new regional headquarters in the Netherlands and close its German manufacturing plant as part of an ongoing realignment of the company. The company will create an operations center near Amsterdam, Welch Allyn said in a news release. The Netherlands “provides a supportive corporate tax structure,” and has other advantages, the company said. The German plant will be closed and work there will be shipped to an existing plant in Tijuana, Mexico to cut costs, the company said. The closing will begin in October 2013 and take six to 12 months. Welch Allyn will continue to operate its facility in Ireland, but over the next two years will move some of those functions to the Netherlands. The actions are a part of the company’s global restructuring announced in September, said Steve Meyer, president and chief executive officer. The restructuring announced Monday will have no impact on the Skaneateles operations, said Jamie Arnold speaking for the company in an email. In September, the company announced that it would cut 10 percent of its global workforce, including 45 jobs from its Skaneateles Falls headquarters.
|
|
|
|
|
|
|
|
|
|
|